Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: A4HSL0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 170 | 174 | PF00656 | 0.562 |
CLV_NRD_NRD_1 | 118 | 120 | PF00675 | 0.362 |
CLV_NRD_NRD_1 | 158 | 160 | PF00675 | 0.623 |
CLV_NRD_NRD_1 | 34 | 36 | PF00675 | 0.406 |
CLV_NRD_NRD_1 | 52 | 54 | PF00675 | 0.447 |
CLV_PCSK_KEX2_1 | 118 | 120 | PF00082 | 0.362 |
CLV_PCSK_KEX2_1 | 160 | 162 | PF00082 | 0.650 |
CLV_PCSK_KEX2_1 | 196 | 198 | PF00082 | 0.631 |
CLV_PCSK_PC1ET2_1 | 160 | 162 | PF00082 | 0.650 |
CLV_PCSK_PC1ET2_1 | 196 | 198 | PF00082 | 0.631 |
CLV_PCSK_SKI1_1 | 161 | 165 | PF00082 | 0.672 |
CLV_PCSK_SKI1_1 | 36 | 40 | PF00082 | 0.411 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.729 |
DOC_CKS1_1 | 150 | 155 | PF01111 | 0.462 |
DOC_CYCLIN_RxL_1 | 32 | 40 | PF00134 | 0.610 |
DOC_CYCLIN_yCln2_LP_2 | 6 | 12 | PF00134 | 0.666 |
DOC_MAPK_gen_1 | 118 | 126 | PF00069 | 0.472 |
DOC_MAPK_MEF2A_6 | 119 | 128 | PF00069 | 0.472 |
DOC_PP2B_LxvP_1 | 179 | 182 | PF13499 | 0.510 |
DOC_PP2B_LxvP_1 | 27 | 30 | PF13499 | 0.597 |
DOC_PP2B_LxvP_1 | 6 | 9 | PF13499 | 0.657 |
DOC_PP4_FxxP_1 | 39 | 42 | PF00568 | 0.597 |
DOC_USP7_MATH_1 | 12 | 16 | PF00917 | 0.734 |
DOC_USP7_MATH_1 | 20 | 24 | PF00917 | 0.635 |
DOC_USP7_UBL2_3 | 160 | 164 | PF12436 | 0.505 |
DOC_USP7_UBL2_3 | 66 | 70 | PF12436 | 0.610 |
DOC_WW_Pin1_4 | 149 | 154 | PF00397 | 0.468 |
DOC_WW_Pin1_4 | 16 | 21 | PF00397 | 0.694 |
LIG_14-3-3_CanoR_1 | 197 | 202 | PF00244 | 0.503 |
LIG_Actin_WH2_2 | 31 | 48 | PF00022 | 0.694 |
LIG_Actin_WH2_2 | 79 | 97 | PF00022 | 0.625 |
LIG_APCC_ABBAyCdc20_2 | 110 | 116 | PF00400 | 0.582 |
LIG_BRCT_BRCA1_1 | 30 | 34 | PF00533 | 0.693 |
LIG_BRCT_BRCA1_2 | 30 | 36 | PF00533 | 0.690 |
LIG_FHA_1 | 137 | 143 | PF00498 | 0.417 |
LIG_FHA_1 | 145 | 151 | PF00498 | 0.400 |
LIG_FHA_1 | 66 | 72 | PF00498 | 0.667 |
LIG_FHA_2 | 181 | 187 | PF00498 | 0.491 |
LIG_FHA_2 | 95 | 101 | PF00498 | 0.635 |
LIG_LIR_Apic_2 | 146 | 151 | PF02991 | 0.387 |
LIG_LIR_Apic_2 | 37 | 42 | PF02991 | 0.600 |
LIG_LIR_Nem_3 | 117 | 123 | PF02991 | 0.458 |
LIG_SH2_GRB2like | 120 | 123 | PF00017 | 0.302 |
LIG_SH2_PTP2 | 123 | 126 | PF00017 | 0.321 |
LIG_SH2_STAP1 | 120 | 124 | PF00017 | 0.321 |
LIG_SH2_STAP1 | 138 | 142 | PF00017 | 0.410 |
LIG_SH2_STAT5 | 123 | 126 | PF00017 | 0.302 |
LIG_SH2_STAT5 | 138 | 141 | PF00017 | 0.420 |
LIG_SUMO_SIM_par_1 | 177 | 184 | PF11976 | 0.464 |
MOD_CK1_1 | 15 | 21 | PF00069 | 0.711 |
MOD_CK2_1 | 180 | 186 | PF00069 | 0.498 |
MOD_CK2_1 | 94 | 100 | PF00069 | 0.643 |
MOD_GlcNHglycan | 168 | 172 | PF01048 | 0.735 |
MOD_GlcNHglycan | 22 | 25 | PF01048 | 0.533 |
MOD_GSK3_1 | 12 | 19 | PF00069 | 0.721 |
MOD_GSK3_1 | 197 | 204 | PF00069 | 0.503 |
MOD_GSK3_1 | 99 | 106 | PF00069 | 0.615 |
MOD_NEK2_1 | 103 | 108 | PF00069 | 0.608 |
MOD_NEK2_1 | 131 | 136 | PF00069 | 0.420 |
MOD_NEK2_1 | 71 | 76 | PF00069 | 0.591 |
MOD_NEK2_1 | 94 | 99 | PF00069 | 0.645 |
MOD_PIKK_1 | 154 | 160 | PF00454 | 0.423 |
MOD_PIKK_1 | 94 | 100 | PF00454 | 0.652 |
MOD_PKA_1 | 196 | 202 | PF00069 | 0.496 |
MOD_PKA_2 | 196 | 202 | PF00069 | 0.496 |
MOD_PKA_2 | 94 | 100 | PF00069 | 0.643 |
MOD_ProDKin_1 | 149 | 155 | PF00069 | 0.464 |
MOD_ProDKin_1 | 16 | 22 | PF00069 | 0.695 |
MOD_SUMO_rev_2 | 40 | 47 | PF00179 | 0.624 |
TRG_ENDOCYTIC_2 | 123 | 126 | PF00928 | 0.302 |
TRG_ER_diArg_1 | 118 | 120 | PF00400 | 0.562 |
TRG_ER_diArg_1 | 159 | 162 | PF00400 | 0.506 |
TRG_ER_diArg_1 | 3 | 6 | PF00400 | 0.709 |
TRG_ER_diArg_1 | 92 | 95 | PF00400 | 0.641 |
TRG_Pf-PMV_PEXEL_1 | 36 | 40 | PF00026 | 0.396 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HSV2 | Leptomonas seymouri | 89% | 98% |
A0A0S4J1S7 | Bodo saltans | 67% | 100% |
A0A1X0NK70 | Trypanosomatidae | 65% | 71% |
A0A3R7RHS1 | Trypanosoma rangeli | 68% | 87% |
A0A3S5H5K7 | Leishmania donovani | 100% | 100% |
A4H4D0 | Leishmania braziliensis | 91% | 100% |
C9ZU79 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 71% | 68% |
E9AKJ4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
Q4QJB4 | Leishmania major | 98% | 100% |